Market Cap 427.22M
Revenue (ttm) 742.90M
Net Income (ttm) 52.60M
EPS (ttm) N/A
PE Ratio 8.28
Forward PE N/A
Profit Margin 7.08%
Debt to Equity Ratio 1.10
Volume 575,900
Avg Vol 847,798
Day's Range N/A - N/A
Shares Out 51.60M
Stochastic %K 58%
Beta 2.34
Analysts Strong Sell
Price Target $12.00

Company Profile

Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States, Canada, and internationally. It operates through Commercial Products, MCM Products, and All Other Revenues segments. The company offers ACAM2000, a smallpox and mpox vaccine; Anthrax Immune Globulin Intravenous (ANTHRASIL), a polyclonal antibody therapeutic for the treatment of inhalational anthrax; Botul...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 240 631 3200
Fax: 240 631 3203
Address:
300 Professional Drive, Suite 400, Gaithersburg, United States
ComradeKomisar
ComradeKomisar Jul. 3 at 7:50 PM
$EBS The Senate NDAA is also flagging anthrax under-preparedness. This could be a revenue stream from DoD, rather than HHS.
1 · Reply
alwayzwong
alwayzwong Jul. 3 at 6:42 PM
$EBS what a joke.
0 · Reply
ComradeKomisar
ComradeKomisar Jul. 3 at 3:31 PM
$EBS 15 jobs now. Canton is getting ready for Substipharm, and may be BundiVx if Emergent could get a piece.
0 · Reply
ComradeKomisar
ComradeKomisar Jul. 3 at 2:35 PM
$EBS ASPR obligations have 'mean-reverted'.
0 · Reply
ComradeKomisar
ComradeKomisar Jul. 3 at 1:31 PM
$EBS It's not even 10% of what is allowed to sell.
0 · Reply
alwayzwong
alwayzwong Jul. 2 at 8:20 PM
1 · Reply
WinstonSmith33
WinstonSmith33 Jul. 2 at 7:47 PM
$EBS But why insiders are getting rid of shares? Maybe because they got them for free?
2 · Reply
alwayzwong
alwayzwong Jul. 2 at 7:42 PM
$EBS would be interesting if we end at or above $8.29
0 · Reply
LVUP
LVUP Jul. 2 at 7:26 PM
1 · Reply
ComradeKomisar
ComradeKomisar Jul. 2 at 5:41 PM
$EBS Expanded access = expanded market. The market is for everyone, the share of the market is another issue altogether. Emergent has more advantages in Canada than the US at this point. Between Trump's antics, and California's malfeasance, we are lucky if our volume share remains over 50%.
0 · Reply
Latest News on EBS
Emergent BioSolutions awarded $52.7M contract modification

2026-06-29T13:25:30.000Z - 5 days ago

Emergent BioSolutions awarded $52.7M contract modification


Emergent BioSolutions Earnings Call Transcript: Q1 2026

Apr 30, 2026, 5:00 PM EDT - 2 months ago

Emergent BioSolutions Earnings Call Transcript: Q1 2026


Emergent BioSolutions Earnings release: Q1 2026

Apr 30, 2026, 5:00 PM EDT - 2 months ago

Emergent BioSolutions Earnings release: Q1 2026


Emergent BioSolutions Slides: Q1 2026

Apr 30, 2026, 5:00 PM EDT - 2 months ago

Emergent BioSolutions Slides: Q1 2026


Emergent BioSolutions Quarterly report: Q1 2026

Apr 30, 2026, 5:00 PM EDT - 2 months ago

Emergent BioSolutions Quarterly report: Q1 2026


Emergent BioSolutions Transcript: AGM 2026

Apr 29, 2026, 9:00 AM EDT - 2 months ago

Emergent BioSolutions Transcript: AGM 2026


Emergent BioSolutions Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 2 months ago

Emergent BioSolutions Proxy statement: Proxy filing


Emergent BioSolutions Proxy statement: Proxy filing

Apr 27, 2026, 8:00 AM EDT - 2 months ago

Emergent BioSolutions Proxy statement: Proxy filing


Emergent BioSolutions Proxy statement: Proxy filing

Apr 22, 2026, 8:00 AM EDT - 2 months ago

Emergent BioSolutions Proxy statement: Proxy filing


Emergent BioSolutions Proxy statement: Proxy filing

Apr 16, 2026, 8:00 AM EDT - 2 months ago

Emergent BioSolutions Proxy statement: Proxy filing


Emergent BioSolutions Proxy statement: Proxy filing

Apr 16, 2026, 8:00 AM EDT - 2 months ago

Emergent BioSolutions Proxy statement: Proxy filing


Emergent BioSolutions Proxy statement: Proxy filing

Mar 20, 2026, 8:00 AM EDT - 3 months ago

Emergent BioSolutions Proxy statement: Proxy filing


Emergent BioSolutions Proxy statement: Proxy filing

Mar 20, 2026, 8:00 AM EDT - 3 months ago

Emergent BioSolutions Proxy statement: Proxy filing


Mpox Is on the Rise. 3 Vaccine Stocks Worth a Second Look.

Mar 17, 2026, 12:49 PM EDT - 3 months ago

Mpox Is on the Rise. 3 Vaccine Stocks Worth a Second Look.

SIGA


Emergent BioSolutions appoints Fowler to board of directors

2026-03-03T13:40:58.000Z - 4 months ago

Emergent BioSolutions appoints Fowler to board of directors


Emergent BioSolutions appoints Fowler to board of directors

2026-03-03T13:27:16.000Z - 4 months ago

Emergent BioSolutions appoints Fowler to board of directors


Emergent BioSolutions reports Q4 EPS (43c) vs. 5c last year

2026-02-26T22:40:37.000Z - 4 months ago

Emergent BioSolutions reports Q4 EPS (43c) vs. 5c last year


Emergent BioSolutions authorizes $50M stock repurchase program

2026-02-26T22:30:21.000Z - 4 months ago

Emergent BioSolutions authorizes $50M stock repurchase program


Emergent BioSolutions Earnings Call Transcript: Q4 2025

Feb 26, 2026, 5:00 PM EST - 4 months ago

Emergent BioSolutions Earnings Call Transcript: Q4 2025


Emergent BioSolutions Annual report: Q4 2025

Feb 26, 2026, 5:00 PM EST - 4 months ago

Emergent BioSolutions Annual report: Q4 2025


Emergent BioSolutions Earnings release: Q4 2025

Feb 26, 2026, 5:00 PM EST - 4 months ago

Emergent BioSolutions Earnings release: Q4 2025


Emergent BioSolutions Slides: Q4 2025

Feb 26, 2026, 5:00 PM EST - 4 months ago

Emergent BioSolutions Slides: Q4 2025


Emergent BioSolutions gets FDA approval of sNDA for Narcan

2026-02-12T23:05:22.000Z - 5 months ago

Emergent BioSolutions gets FDA approval of sNDA for Narcan


Emergent BioSolutions Earnings Call Transcript: Q3 2025

Oct 29, 2025, 5:00 PM EDT - 8 months ago

Emergent BioSolutions Earnings Call Transcript: Q3 2025


Emergent BioSolutions Quarterly report: Q3 2025

Oct 29, 2025, 5:00 PM EDT - 8 months ago

Emergent BioSolutions Quarterly report: Q3 2025


Emergent BioSolutions Earnings release: Q3 2025

Oct 29, 2025, 5:00 PM EDT - 8 months ago

Emergent BioSolutions Earnings release: Q3 2025


Emergent BioSolutions Slides: Q3 2025

Oct 29, 2025, 5:00 PM EDT - 8 months ago

Emergent BioSolutions Slides: Q3 2025


Emergent BioSolutions Earnings Call Transcript: Q2 2025

Aug 6, 2025, 5:00 PM EDT - 11 months ago

Emergent BioSolutions Earnings Call Transcript: Q2 2025


Emergent BioSolutions Quarterly report: Q2 2025

Aug 6, 2025, 5:00 PM EDT - 11 months ago

Emergent BioSolutions Quarterly report: Q2 2025


Emergent BioSolutions Earnings release: Q2 2025

Aug 6, 2025, 5:00 PM EDT - 11 months ago

Emergent BioSolutions Earnings release: Q2 2025


Emergent BioSolutions Slides: Q2 2025

Aug 6, 2025, 5:00 PM EDT - 11 months ago

Emergent BioSolutions Slides: Q2 2025


ComradeKomisar
ComradeKomisar Jul. 3 at 7:50 PM
$EBS The Senate NDAA is also flagging anthrax under-preparedness. This could be a revenue stream from DoD, rather than HHS.
1 · Reply
alwayzwong
alwayzwong Jul. 3 at 6:42 PM
$EBS what a joke.
0 · Reply
ComradeKomisar
ComradeKomisar Jul. 3 at 3:31 PM
$EBS 15 jobs now. Canton is getting ready for Substipharm, and may be BundiVx if Emergent could get a piece.
0 · Reply
ComradeKomisar
ComradeKomisar Jul. 3 at 2:35 PM
$EBS ASPR obligations have 'mean-reverted'.
0 · Reply
ComradeKomisar
ComradeKomisar Jul. 3 at 1:31 PM
$EBS It's not even 10% of what is allowed to sell.
0 · Reply
alwayzwong
alwayzwong Jul. 2 at 8:20 PM
1 · Reply
WinstonSmith33
WinstonSmith33 Jul. 2 at 7:47 PM
$EBS But why insiders are getting rid of shares? Maybe because they got them for free?
2 · Reply
alwayzwong
alwayzwong Jul. 2 at 7:42 PM
$EBS would be interesting if we end at or above $8.29
0 · Reply
LVUP
LVUP Jul. 2 at 7:26 PM
1 · Reply
ComradeKomisar
ComradeKomisar Jul. 2 at 5:41 PM
$EBS Expanded access = expanded market. The market is for everyone, the share of the market is another issue altogether. Emergent has more advantages in Canada than the US at this point. Between Trump's antics, and California's malfeasance, we are lucky if our volume share remains over 50%.
0 · Reply
KnuckleSandwich
KnuckleSandwich Jul. 2 at 5:20 PM
$EBS EBS continues to grind out more market share https://emergentbiosolutions.ca/media-statement/emergent-recognizes-ontarios-proposed-provincial-legislation-to-increase-access-to-naloxone-in-public-spaces/
1 · Reply
ComradeKomisar
ComradeKomisar Jul. 2 at 3:24 PM
$EBS [...] The effort to bolster staff on biosecurity comes as the administration has activated responses across agencies to combat fast-moving health threats. A deadly Ebola outbreak centered in the Democratic Republic of Congo has led to one case in France, while New World screwworm threatens US cattle. It also recently faced a hantavirus threat after an outbreak on a cruise ship. Staffing across health leadership in the Trump administration has been strained. The FDA, Centers for Disease Control and Prevention and the Administration for Strategic Preparedness and Response don’t have permanent leadership in place. Jay Bhattacharya, director of the National Institutes of Health, is also acting in the capacity of the CDC director while the agency juggles multiple outbreak responses. [...]
0 · Reply
ComradeKomisar
ComradeKomisar Jul. 2 at 2:46 PM
$EBS $SIGA 🙏 https://www.rollingstone.com/politics/politics-features/maha-maga-alliance-fracture-robert-kennedy-jr-1235582070/
0 · Reply
Tradewind74
Tradewind74 Jul. 2 at 2:35 PM
$EBS stuck here
0 · Reply
ComradeKomisar
ComradeKomisar Jul. 2 at 2:34 PM
$EBS Back to daily programming post index/ETF rebalancing.
0 · Reply
billywilliamz
billywilliamz Jul. 1 at 10:56 PM
1 · Reply
ComradeKomisar
ComradeKomisar Jul. 1 at 10:07 PM
$EBS Again, the funds are there, they are not being spent, and administration positions are not staffed. This was the "grand plan" of MAHA coalition, and Project 2025.
0 · Reply
alwayzwong
alwayzwong Jul. 1 at 8:06 PM
$EBS looks ready..
0 · Reply
2romeo2
2romeo2 Jul. 1 at 7:04 PM
$EBS
0 · Reply
alwayzwong
alwayzwong Jul. 1 at 5:43 PM
$EBS you should work for wall st.
0 · Reply
alwayzwong
alwayzwong Jul. 1 at 5:42 PM
$EBS fact is, the pandemic preparedness department needs funding. We stand to benefit whenever the money starts flowing to these departments.
0 · Reply
Unicorn2020
Unicorn2020 Jul. 1 at 5:41 PM
$EBS Another successful trade closed on June 30. Realized $74,335.48 in profit, bringing my gains for the first half of 2026 to over $74K.
0 · Reply